Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Study Shows China Has Double Global MDR TB Rate

This article was originally published in PharmAsia News

Executive Summary

A new study says China has double the rate of multidrug-resistant tuberculosis as the world in general. The joint Chinese, Dutch study put that type of TB at 9.3 percent in China, nearly double the 4.8 percent rate in the rest of the world. The researchers said a fourth of the world's previously treated patients now with MDR-TB are located in China. The nation also accounts for second-highest prevalence of the disease, behind only Russia. China's CDC led the researchers in the study covering the past nine years. It found half of previously treated patients are now resistant to at least one TB drug. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts